摘要
目前第三代芳香化酶抑制剂(Aromatase Inhibitors,AIs)已广泛应用于早期及转移性乳腺癌的辅助治疗。为绝经后激素受体阳性乳腺癌患者的治疗提供了新的一条途径。然而,由于AIs抑制绝经后乳腺癌患者体内雄激素转变为雌激素过程中芳香化酶的活性导致体内雌激素水平降低,而雌激素对骨组织具有保护作用,因此服用芳香化酶抑制剂的患者将会出现骨丢失。
出处
《实用肿瘤学杂志》
CAS
2010年第4期324-327,共4页
Practical Oncology Journal
参考文献21
-
1Lonning PE,Geisler J.Indications and limitations of third-generation aromatase inhibitors[J].Expert Opin Invest Drugs,2008,17(5):723-739.
-
2王利霞,施红旗,朱寿田.新辅助内分泌治疗在绝经后乳腺癌中的应用[J].实用肿瘤学杂志,2008,22(3):259-260. 被引量:6
-
3Greep N,Giuliano A,Hansen N,et al.The effects of adjuvant chemotherapy on bone density in postmenopausal women with early breast cancer[J].Am J Med,2003,114(8):653-659.
-
4Shapiro CL,Manola J,Leboff M.Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer[J].J Clin Oncol,2001,19(14):3306-3311.
-
5Kudchadkar R,O' Regan RM.Aromatase inhibitors as adjuvant therapy for post menopausal patients with early stage breast cancer[J].CA Cancer J Clin,2005,55(3):145-163.
-
6Raisz LG.Pathogenesis of osteoporosis:concepts,conflicts,and p rospects[J].J Clin Invest,2005,115(12):3318-3325.
-
7Eastell R,Adams JE,Coleman RE,et al.Effect of anastrozole on bone mineral density:5-year results from the anastrozole,tamoxifen,alone or in combination trial 18233230[J].Clin Oncol,2008,26(7):1051-1057.
-
8Forbes JF,Cuzick J,Buzdar A,et al.Effect of anastrozole and tamoxifen asadjuvant treatment for early-stage breast cancer:100-month analysis of the ATAC trial[J].Lancet Oncol,2008,9(1):315-316.
-
9Jakesz R,Jonat W,Gnant M,et al.Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen:combined results of ABCSG trial 8 and ARNO 95 trial[J].Lancet,2005,366(9484):455-462.
-
10Thürlimann B,Keshaviah A,Coates AS,et al.A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer[J].N Engl J Med,2005,353:2747-2757.
二级参考文献10
-
1王德伟.内分泌治疗高龄乳腺癌近期疗效观察[J].中国热带医学,2005,5(6):1273-1274. 被引量:2
-
2丁小文,郑树.乳腺癌新辅助内分泌治疗研究进展[J].国际肿瘤学杂志,2006,33(1):38-41. 被引量:12
-
3王晓红,章爱斌,倪俊,顾凤元.来曲唑在绝经后乳腺癌患者新辅助化疗中的应用价值探讨[J].浙江医学,2006,28(6):502-503. 被引量:9
-
4马特,李爽,张强,赵林,龙飞,张斌.绝经后乳腺癌新辅助内分泌治疗近期疗效观察[J].中国肿瘤临床,2007,34(12):706-708. 被引量:10
-
5Dixon JM, Anderson TJ, Miller WR. Neoadiuvant endocrine therapy of breast cancer: a surgical perspective[J]. Eur J Cancer,2002,38(17) :2214-2221.
-
6Milla Santos A, Milla L,Calvo N, et al. Anastroloze as neoadjuvant therapy for patients with hormone-depend- ent, locally-advanced breast cancer. Anticancer Res [J]. 2004, 24(2C):1315-1318.
-
7Eiermann W, Paepke S, Appfelstaedt J, et al. Preoperative treatment of postmenopausal breast cancer patients with letrozole., a randomized double-blind multicenter study[J]. Ann Oncol,2001,12(11) : 1527-1532.
-
8Dixon JM,Love CD,Bellamy CO,et al. Letrozole as primary medical therapy for locally advanced and large operable breast cancer[J]. Breast Cancer ResTreat,2001, 66(3):191-199.
-
9Ellis MJ,Coop A, Singh B,et al. Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for Erb-1 and/or Erb-2 positive, estrogen receptor positive primary breast cancer: evidence from a phase Ill randomized trial[J]. Clin Oncol,2001,19(18) : 3808-3816.
-
10霍彦平,高峰,吕晶.绝经后乳腺癌术前内分泌治疗的近期疗效[J].新医学,2003,34(12):736-737. 被引量:3
共引文献5
-
1陈伟财,何劲松,王敏,吴恢升,王先明.老年乳腺癌患者新辅助内分泌治疗的临床应用[J].中国癌症杂志,2011,21(5):359-362. 被引量:23
-
2姚慧韬,吴康康.来曲唑用于绝经后乳腺癌手术前治疗的临床研究[J].中国基层医药,2012,19(3):395-396. 被引量:6
-
3董敏,陈孝,王晓东.乳腺癌新辅助内分泌治疗方法的研究进展[J].中国卫生产业,2012,9(2):117-117. 被引量:1
-
4颜劲.三苯氧胺与来曲唑在绝经后乳腺癌新辅助内分泌治疗中的疗效对比[J].中国现代药物应用,2013,7(8):88-90. 被引量:6
-
5李学恩.ER阳性乳腺癌根治术后辅助内分泌治疗的效果分析[J].中国实用医药,2018,13(15):11-13. 被引量:1
同被引文献12
-
1Morales L, Pans S, Verschueren K, et al. Prospective studyto assess short 一 term intra - articular and tenosynovia]changes in the aromatase inhibitor - associated arthralgiasyndrome[J].J Clin Oncol,2008,26( 19) :3147 -3152.
-
2Dizdar 0,Ozcakar L,Malas FU,et al. Sonographic and elec-trodiagnostic evaluations in patients with aromatase inhibitor-related arthralgia[ J]. J Clin Oncol,2009,27 (30) :4955-4960.
-
3Santen R. Effect of endocrine therapies on bone in breastcancer patients[ J] . J Clin Endocrinol Metab,2011,96(2):308 -319.
-
4Jingxuan W,Qingyuan Z,Shi j,et al. Immoderate inhibitionof estrogen by anastrozole enhances the severity of experi-mental polyarthritis[ J]. Exp Gerontol,2009 ,44(6 -7) :398-405.
-
5Jingxuan W , Qingyuan Z, Shi J, et al. Genistein modulateimmune responses in collagen - induced rheumatoid arthritismodel [ J]. Maturitas, 2008 ,59(4) :405 -412.
-
6Zhang Q, Tang D, Zhao H. Immunological therapies can re-lieve aromatase inhibitor - related joint symptoms in breastcancer survivorsf J]. Am J Clin Oncol,2010,33(6) :557 -560.
-
7Kong YY,Feige U,Sarosi L,et al. Activated T cells regu-late bone loss and joint destruction in adjuvant arthritisthrough osteoprotegerin ligand [ J ]. Nature, 1999, 402(6759):304-309.
-
8Georgiana K,Henry G,Rowan C,et al. Effect of denosumabon bone mineral density in women receiving adjuvant aro-matase inhibitors for non - metastatic breast cancer: sub-group analyses of a phase 3 study [ J ]. Breast Cancer Re-search and Treatment,2009,118( 1 ) :81 - 87.
-
9Sato K, Suematsu A,Okamoto K, et al. Thl7 functions asan osteoclastogenic helper T cell subset that links T cellactivation and bone destruction [ J ]. J Exp Med, 2006,203(12):2673 -2682.
-
10刘思佳,孙占娟,周亚欧,左晓霞.^(99)Tc-亚甲基二膦酸盐对胶原诱导性关节炎大鼠骨侵蚀的治疗作用[J].国际病理科学与临床杂志,2010,30(2):123-129. 被引量:8
-
1胡震.乳腺癌治疗相关性骨丢失的发生机制[J].癌症进展,2008,6(6):625-627. 被引量:4
-
2他莫西芬不能防止乳腺癌妇女由于化疗引起停经而导致的骨丢失[J].国外医学(内分泌学分册),2003,23(B04):70-70.
-
3李惠平,刘晓光.乳腺癌患者骨丢失的管理[J].肿瘤防治研究,2012,39(6):619-622. 被引量:1
-
4马建辉.关注前列腺癌患者的骨健康[J].中华医学杂志,2010,90(14):940-941.
-
5应用芳香化酶抑制剂的绝经后乳腺癌患者骨丢失和骨质疏松的预防诊断和处理共识[J].中华肿瘤杂志,2013,35(11):876-879. 被引量:14
-
6王万忠,种瑞峰,郑敏,齐恒.第三代芳香化酶抑制剂在绝经后乳腺癌新辅助内分泌治疗中的应用[J].中国医学创新,2011,8(22):192-195. 被引量:2
-
7李宁,万冬桂,李爽.乳腺癌患者相关骨丢失的诊治现状与展望[J].中国骨质疏松杂志,2009,15(11):840-843. 被引量:3
-
8沈恩超,王水,凌立君,张建新.芳香化酶抑制剂在乳腺癌内分泌治疗中的研究进展[J].江苏大学学报(医学版),2006,16(5):456-458. 被引量:9
-
9徐曙光,朱敬之,瞿顺,吴志勇.骨丢失在乳腺癌治疗中的意义与临床应对[J].中华临床医师杂志(电子版),2012,6(4):110-113. 被引量:2
-
10蒋沈君,刘云霞,杨洁文.自拟疏肝补肾方治疗乳腺癌相关骨质疏松症21例观察[J].浙江中医杂志,2015,50(7):518-518. 被引量:14